Open house drug discount agreements Tolterodin, ATC G04BD07
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tolterodin, ATC G04BD07
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated contract value or maximum framework amount is disclosed, making it impossible to assess the potential reve...
If a competitive discount contract for the same active ingredient is concluded, the open-house agreement automatically...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until May 2027
- Supply of Tolterodin (ATC G04BD07) pharmaceutical products under non-exclusive discount agreements with AOK Bayern.
Show full summary
Open-house model for non-exclusive drug discount agreements for Tolterodin (ATC G04BD07) with AOK Bayern. All qualified pharmaceutical companies can join. No estimated value provided. Contract period: 1 June 2025 to 31 May 2027. Submission deadline: 5 April 2027. Single lot.
Risks
No estimated contract value or maximum framework amount is disclosed, making it impossible to assess the potential reve...
If a competitive discount contract for the same active ingredient is concluded, the open-house agreement automatically...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible.
Administrative
- Must submit signed declaration of reliability.
- Contracts must be submitted in duplicate if in paper form, or electronically with qualified electronic signature.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house drug discount agreements Tolterodin, ATC G04BD07
Non-exclusive discount agreements for Tolterodin (ATC G04BD07). All qualified pharmaceutical companies can join at any time during the contract period.
Location
Duration
Category
Award Criteria
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Tolterodin, ATC G04BD07
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Procurement Details
- Publication date
- 15 Apr 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 249772-2025
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No estimated contract value or maximum framework amount is disclosed, making it impossible to assess the potential reve...
If a competitive discount contract for the same active ingredient is concluded, the open-house agreement automatically...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications